Impact of Email Drug Information on Prescription Sales
Author Information
Author(s): Edward Christina, Himmelmann Anders, Wallerstedt Susanna M
Primary Institution: Department of Health, Pharmaceutical Unit, Regionens hus, Göteborg, Sweden
Hypothesis
Does an email with a drug information attachment affect the sales of prescribed drugs?
Conclusion
An email with a drug information attachment may influence sales of prescribed drugs, but the design of the attachment does not seem to matter.
Supporting Evidence
- The absolute change in percentage rizatriptan was greater in the intervention groups compared to the control group.
- No difference in sales was found between the two different email attachment designs.
- The study involved a total of 119 primary care units in western Sweden.
Takeaway
Sending doctors an email with drug information can help them sell more of a specific medicine, but it doesn't matter how long the email is.
Methodology
The study randomized 119 heads of primary care units to receive different email attachments or no information, then compared changes in drug sales.
Potential Biases
The forwarding process of the emails may have influenced the results, as control group doctors might have received the information.
Limitations
The study only assessed short-term effects on sales and did not confirm if the emails reached the prescribing doctors.
Participant Demographics
Heads of primary care units in western Sweden.
Statistical Information
P-Value
0.031
Confidence Interval
25th – 75th percentile: -3 – 7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website